🇧🇷 Peptide Regulations in Brazil

Legal Status

Brazil regulates pharmaceuticals under Law No. 6.360/1976 and its implementing regulations, with ANVISA serving as the primary regulatory authority. Peptides intended for therapeutic use must be registered with ANVISA before commercial sale. Brazil has a robust generic and biosimilar regulatory framework, and several peptide drugs (including growth hormone formulations) are registered and available through the Unified Health System (SUS). Research chemicals for in vitro use can be imported through registered chemical distributors, but importing pharmaceutical-grade peptides for personal use is heavily restricted. ANVISA has been modernising its regulatory framework, with Resolution RDC No. 753/2022 updating pharmaceutical registration requirements.

Compounding Rules

• Compounding (manipulação magistral) is regulated under RDC No. 67/2007 and is well-established in Brazil's pharmacy system.
• Compounding pharmacies (farmácias de manipulação) must hold an ANVISA operating authorisation and comply with Good Compounding Practices.
• Magistral formulas require a prescription from a registered healthcare professional.
• Officinal formulas may be prepared according to the Brazilian Pharmacopoeia without a specific prescription.
• Brazil's compounding pharmacy sector is one of the largest in the world — many peptide preparations are available through this channel.
• ANVISA periodically audits compounding pharmacies and can suspend or revoke operating authorisations for non-compliance.

Personal Importation

• ANVISA's RDC No. 81/2008 governs the importation of pharmaceutical products, including personal importation.
• Personal importation is permitted for products without a registered equivalent in Brazil, subject to ANVISA authorisation.
• The importer must provide a medical prescription and a declaration of personal-use intent.
• Quantities are generally limited to the amount needed for the prescribed treatment duration.
• Brazilian customs (Receita Federal) actively screens incoming packages and works with ANVISA to intercept unauthorized pharmaceutical imports.
• Importing controlled substances (portaria SVS 344/1998) requires specific ANVISA authorisation.

How to Verify Legality

• Search ANVISA's product registration database (Consulta de Produtos) at gov.br/anvisa.
• Check the Brazilian Pharmacopoeia for quality monographs and standards.
• Verify pharmacy operating authorisations through ANVISA's establishment database.
• Review Portaria SVS 344/1998 for the controlled substances list.
• Contact ANVISA's customer service (Atendimento ao Cidadão) for regulatory queries about specific products.